Saneca Pharmaceuticals has been acquired by AZC Group

December 2025 — AZC Group has acquired controlling ownership of Saneca Pharmaceuticals AS, a Slovakia-based pharmaceutical contract development and manufacturing organization (CDMO).

Saneca Pharmaceuticals is a Slovakia-based pharmaceutical CDMO focused on the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients (APIs). The company operates across the pharmaceutical value chain, offering end-to-end services from product development to commercial-scale manufacturing. It serves a diversified base of pharmaceutical companies, primarily in Europe, and produces over 1,300 SKUs across a broad range of dosage forms.

AZC is a diversified industrial group headquartered in Slovakia, operating across multiple sectors including biofuels, chemicals, agriculture, transport and logistics. The group manages a portfolio of industrial assets across several countries and integrates upstream and downstream activities within its businesses.

Our role in the transaction

Oaklins’ team in Slovakia acted as the sole financial advisor to the seller.